Pr Christophe Massard, Oncologue médical, expert vessie, expert prostate

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. (26 août 2025)
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]. (20 août 2025)
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. (31 juil. 2025)
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. (29 juil. 2025)
[Proposals to develop innovation and research in cancer and optimize care for patients affected by cancer]. (9 juil. 2025)